PHARMACY PRACTICE-BIOSIMILARS Senate SponsorsSen. Antonio Muņoz-Iris Y. Martinez-Pamela J. Althoff-Melinda Bush, David Koehler, Mattie Hunter and Dan Kotowski 1/13/2015SenateSession Sine Die 225 ILCS 85/19.5 newAmends the Pharmacy Practice Act. Provides that a pharmacist may substitute a prescription biosimilar product for a prescribed biological product under certain circumstances. Provides that the Board shall adopt rules for compliance with these provisions. Effective immediately. 2/15/2013SenateFiled with Secretary by Sen. Antonio Muņoz 2/15/2013SenateFirst Reading 2/15/2013SenateReferred to Assignments 2/15/2013SenateAdded as Chief Co-Sponsor Sen. Iris Y. Martinez 2/15/2013SenateAdded as Chief Co-Sponsor Sen. Pamela J. Althoff 2/15/2013SenateAdded as Chief Co-Sponsor Sen. Melinda Bush 2/28/2013SenateAdded as Co-Sponsor Sen. David Koehler 2/28/2013SenateAdded as Co-Sponsor Sen. Mike Jacobs 3/1/2013SenateAdded as Co-Sponsor Sen. William Delgado 3/5/2013SenateAdded as Co-Sponsor Sen. Steven M. Landek 3/6/2013SenateAssigned to Executive 3/6/2013SenateSponsor Removed Sen. William Delgado 3/7/2013SenateAdded as Co-Sponsor Sen. Mattie Hunter 3/12/2013SenateAdded as Co-Sponsor Sen. Dan Kotowski 3/12/2013SenateSponsor Removed Sen. Mike Jacobs 3/13/2013SenatePostponed - Executive 3/14/2013SenateSponsor Removed Sen. Steven M. Landek 3/20/2013SenateDo Pass Executive; 011-003-000 3/20/2013SenatePlaced on Calendar Order of 2nd Reading March 21, 2013 4/24/2013SenateSecond Reading 4/24/2013SenatePlaced on Calendar Order of 3rd Reading April 25, 2013 4/29/2013SenateRule 2-10 Third Reading Deadline Established As May 3, 2013 5/2/2013SenateRule 2-10 Third Reading Deadline Established As May 31, 2013 7/8/2013SenateRule 2-10 Committee/3rd Reading Deadline Established As November 7, 2013 8/9/2013SenatePursuant to Senate Rule 3-9(b) / Referred to Assignments 1/13/2015SenateSession Sine Die